 |
 Educational Program
|
|
|
New Developments in the Medical Treatment of Breast Cancer
Monday, March 6, 6:00-8:00 PM ET
Featuring Dr. Maura N. Dickler, Medical Oncologist, Memorial Sloan Kettering Cancer Center
JCC Manhattan
334 Amsterdam Ave
New York, NY 10023
|
|
|
|
Facing Forward: When Cancer Changes the Road Ahead
Thursday, February 9, 12:00-1:00 PM ET
Featuring Julie Larson, LCSW
|
|
|
|
DCIS: What You Need to Know
Wednesday, March 22, 12:00-1:00 PM ET
Featuring Deborah Collyar, founder of Patient Advocates in Research
|
|
|
New Spanish-language webinar this month
|
|
Please call (212) 382-2111 to register for breast cancer groups and (212) 719-1204 for ovarian cancer groups.
|
Tues, Mar 14, 6:00-7:30 PM
Tues, Mar 28, 6:00-7:30 PM
Fri, Mar 10, 6:00-7:30 PM
Fri, Mar 24, 12:30-2:00 PM
Breast Cancer Post-Treatment
Wed, Mar, 6:00-7:30 PM
Metastatic In-Person Lunchtime
Mon, Mar 13, 12:30-1:30 PM
Mon, Mar 27, 12:30-1:30 PM
|
|
|
DCIS
Mon, Mar 13, 6:00-7:30 PM
Ovarian Cancer: Ongoing
Wed, Mar 15, 6:00-7:30 PM
Newly Diagnosed Ovarian Cancer
Wed, Mar 1, 6:00-7:30 PM
Caregivers Group
Tues, Mar 14, 6:00-7:30 PM
Coping with Aromatase Inhibitors and Tamoxifen
Tues, Mar 21, 6:00-7:30 PM
|
|
|
Support Groups from Your Home
|
|
Please call (212) 382-2111 to register for phone groups and receive instructions on how to participate.
|
Wed, Mar 1, 8:00-9:00 PM ET
Mon, Mar 6, 13, 20, 27, 4:00-5:00 PM ET
Thurs, Mar 2, 9, 16, 23, 6:00-7:00 PM ET
There is no group on March 30.
Lymphedema Telephone Support Group
Thurs, Mar 9, 8:15-9:15 PM ET
|
|
We'd like to speak with you!
|
We are gathering stories of women who have participated in clinical trials for all stages of breast and ovarian cancers as part of our #ClinicalTrialsTuesday campaign! If you would like your story to be featured on our blog and social media, write to us and we'll set you up. Your identity can be kept anonymous if desired.
|
Did You Miss the Webinar on Ovarian Cancer and Clinical Trials?
|
You can watch it online
here! C
ourtney Hudson, CEO & Co-Founder of EmergingMed, explained the basics of clinical trials and the process of developing new treatments in the emerging age of personalized medicine and immunotherapy.
|
Find Your Community!
|
| Over 1000 women are finding and sharing support on SHARE's HealthUnlocked sites. Click below to find the community most relevant to you! |
Our workplace wellness program Pink and Teal Seminars is looking for healthy survivors of breast or ovarian cancer who are comfortable talking about their experience before a group. You will receive training that will equip you to share your experience in a way that will empower men and women to take control of their health.
Contact Arlene to get connected.
|
SHARE serves on the board of the
N
ational Breast Cancer Coalition (NBCC), which recently announced its
legislative priorities. They include securing $150 Million for the Department of Defense Breast Cancer Research Program in 2017; guaranteeing access to quality, evidence-based healthcare; and ensuring the participation of educated patient advocates in all levels of healthcare decision making.
Join NBCC at its annual Advocate Leadership Summit on May 20-23 in Washington, DC. and participate in Lobby Day to advocate for these priorities.
Learn more and register here.
|
| Applications Being Accepted for Camp Mak-A-Dream |
|
Applications are now open for Camp Mak-A-Dream's ovarian cancer women's Spring retreat,
May 4-8 in Montana!
The camp's 5-day medically-supervised retreats afford women with cancer the chance to focus on themselves, have fun, and build connection with women like them. Programming is a mix of confidence-building activities like the zip line and practical sessions on art therapy, side effects, and more. They are for women young and old, in treatment or out.
Registration opens
June 1st
for the Fall ovarian cancer retreat and general women's
cancer retreat.
|
Support SHARE by Subscribing to Cancer Today
|
|
Published quarterly by the American Association for Cancer Research, Cancer Today magazine empowers patients, survivors and caregivers with reliable, reader-friendly reporting on the latest advances in cancer research, inspiring articles about cancer survivors, insider looks at people driving progress against cancer, guidance on being an active partner in one's treatment and more.
SHARE will receive 30 percent of the cost of subscriptions purchased through
this subscription page. Sample articles from the latest issue
here.
|
Call SHARE's Toll-Free Helpline
Talk to a survivor or a caregiver who's been there.
844-ASK-SHARE
|
SHARE's clinical trial programming is funded in part by
Medivation
.
|
|
|
